Cartesian Therapeutics, Inc. - PE Ratio

The PE Ratio as of July 2026 (TTM) for Cartesian Therapeutics, Inc. (RNAC) is -1.99

According to Cartesian Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.99. This represents a change of -1039.40% compared to the average of 0.21 of the last 4 quarters.

Cartesian Therapeutics, Inc. (RNAC) Historical PE Ratio (quarterly & annually)

How has RNAC PE Ratio performed in the past?

The mean historical PE Ratio of Cartesian Therapeutics, Inc. over the last ten years is -3.31. The current -1.99 PE Ratio has changed 5.92% with respect to the historical average. Over the past ten years (40 quarters), RNAC's PE Ratio was at its highest in in the June 2021 quarter at 25.91. The PE Ratio was at its lowest in in the December 2024 quarter at -64.89.

Cartesian Therapeutics, Inc. (RNAC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cartesian Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cartesian Therapeutics, Inc. (RNAC) Average PE Ratio

How has RNAC PE Ratio performed in the past?

The current PE Ratio of Cartesian Therapeutics, Inc. (RNAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cartesian Therapeutics, Inc. (RNAC) PE Ratio vs. Peers

How is RNAC’s PE Ratio compared to its peers?

Cartesian Therapeutics, Inc.’s PE Ratio is greater than Eupraxia Pharmaceuticals Inc. (-5.68), greater than Inventiva S.A. (-2.07), greater than Nautilus Biotechnolgy, Inc. (-2.31), greater than Orchestra BioMed Holdings, Inc. (-2.68), greater than MediWound Ltd. (-6.35), less than Aardvark Therapeutics, Inc. Common Stock (-1.66), greater than Fennec Pharmaceuticals Inc. (-31.42), greater than Avalo Therapeutics, Inc. (-3.26), less than Neonc Technologies Holdings, Inc. (-1.80), greater than Genfit S.A. (-7.90),

Build a custom stock screener for Cartesian Therapeutics, Inc. (RNAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cartesian Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cartesian Therapeutics, Inc. (RNAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cartesian Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.